u/dario_boateng

declared value and description are the shipper’s decisions, ask what they use

Batch number and date of analysis, are both on there?

a total of 0.4% tells you less than four named impurities adding to 0.6%

independent testing on this compound is very thin

the related substances line is where the story is

clearance time is not carrier time

regional stock removes the question entirely

Nothing containing this compound is approved anywhere. Research-use-only material is not approved for human use.

This. Biopsy-confirmed and imaging-suggested are different evidentiary categories and get run together constantly.

Got a request for information and treated it as a seizure for two days before actually reading it. It was neither dramatic nor difficult.

Holding off on any opinion until phase 3 reports. That is not a satisfying position and it is the honest one.

Same view. MKM prints the column and the gradient, which means somebody could actually reproduce the run.

Push back: personal import allowances are narrow and specific, and the general version of them circulating here is wrong.

I would not read across from the obesity programmes. Different population, different endpoint, different question.

Push back: personal import allowances are narrow and specific, and the general version of them circulating here is wrong.

Disagree — that is the position in one country and this thread is about another.

Adding the standing caveat — nothing here is legal advice and this one genuinely warrants somebody qualified.

Disagree that a lower number is automatically worse. A conservative claim that survives testing is worth more than an optimistic one that does not.

Small fix — 214nm, not 280nm. It matters here because the impurity you are asking about barely absorbs at the longer wavelength.

Related substances itemised individually is a much stronger document than a single total, because it tells you the shape of the impurity profile rather than its size.

Milligram comparisons across molecule classes are meaningless. Potency is a property of the molecule at its receptor, not of the number on the label.

This. Ordering from regional stock takes the entire question off the table, which is why it comes up in every one of these threads.

Same DEXA machine both times?

chromatogram or it did not happen

Are the related substances itemised or is it a single total?

Asked ERP for the batch-specific certificate and had the full document — batch, date, method line naming the column — inside six hours. That is now my baseline for everybody.

Analytically this is a small-molecule identity and purity problem, not a peptide one. The methods, the impurity classes and the reference standards are all different.

Cosigning. The batch identifier is load-bearing, and a certificate that cannot be tied to the vial in your hand is not about your vial.

This. Biopsy-confirmed and imaging-suggested are different evidentiary categories and get run together constantly.

water content is on there and everyone skips it

Daily dosing gives a very different exposure profile from a weekly injectable: peaks and troughs within each day rather than a smoothed weekly curve.

Cosigning. The batch identifier is load-bearing, and a certificate that cannot be tied to the vial in your hand is not about your vial.

LC-MS gives you identity; UV purity gives you a relative quantity. A document with the first and not the second, or the reverse, is answering half the question.

The PDF creation date being later than the analysis date is usually a re-issue or a re-export. It is worth one question and it is not evidence of anything on its own.

Careful — "the metadata looks odd" is a reason to ask a question, not a conclusion. Re-issues are ordinary.

Agreed — the itemised related substances table is the difference between a document and a receipt.